Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Ginseng, a promising choice for SARS-COV-2: A mini review

  • Ratan, Zubair Ahmed (Department of Biomedical Engineering, Khulna University of Engineering & Technology) ;
  • Mashrur, Fazla Rabbi (Department of Biomedical Engineering, Khulna University of Engineering & Technology) ;
  • Runa, Nusrat Jahan (Sylhet MAG Osmani Medical College) ;
  • Kwon, Ki Woong (Department of Integrative Biotechnology, Sungkyunkwan University) ;
  • Hosseinzadeh, Hassan (School of Health and Society, University of Wollongong) ;
  • Cho, Jae Youl (Department of Integrative Biotechnology, Sungkyunkwan University)
  • Received : 2021.12.29
  • Accepted : 2022.01.16
  • Published : 2022.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

The current Covid-19 pandemic has changed the entire world and bought so many unprecedented challenges to the scientific community. More than 5 million people died due to the SARS-COV-2 outbreak. For many thousands of years, ginseng, the traditional herb has been used for various infectious diseases by traditional healers. Ginseng showed promising antiviral effects by modulating both natural and acquired immunity. Ginseng might be used as a potential therapeutic agent to prevent SARS-CoV-2 infection along with the vaccine. In this current review, we offer an alternative approach for SARS-COV-2 prevention during this unprecedented pandemic.

Keywords

Acknowledgement

This research was funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF), the Ministry of Science and ICT, South Korea (2017R1A6A1A03015642) and also supported by the Korean society of ginseng (2020), South Korea.

References

  1. Haidere MF, Ratan ZA, Nowroz S, Zaman SB, Jung Y-J, Hosseinzadeh H, Cho JY. COVID-19 vaccine: critical questions with complicated answers. Biomolecul Therapeut 2021;29:1. https://doi.org/10.4062/biomolther.2020.178
  2. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang X, Zheng X-S, Zhao K, Chen Q-J, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-3. https://doi.org/10.1038/s41586-020-2012-7
  3. Mashrur FR, Roy AD, Chhoan AP, Sarker S, Saha A, Hasan SMN, Saha S. Impact of demographic, environmental, socioeconomic, and government intervention on the spreading of COVID-19. Clin Epidemiol. Glob. Health 2021;12:100811. https://doi.org/10.1016/j.cegh.2021.100811
  4. Pal M, Berhanu G, Desalegn C, Kandi V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus 2020;12. e7423-e7423.
  5. Zhang L, Zhao W, Sun B, Huang Y, Glanzel W. How scientific research reacts to international public health emergencies: a global analysis of response patterns. Scientometrics 2020:1-27.
  6. Huremovic D. Brief history of pandemics (Pandemics throughout history). Psychiatry of pandemics: a mental health response to infection outbreak. 2019. p. 7-35.
  7. Yimer G, Ekuadzi E, Fasinu P, de Melo AC, Pillai G. Traditional medicines for COVID-19: perspectives from clinical pharmacologists. Br J Clin Pharmacol 2021;87:3455-8. https://doi.org/10.1111/bcp.14981
  8. Anyinam C. Availability, accessibility, acceptability, and adaptability: four attributes of African ethno-medicine. Soc Sci Med 1987;25:803-11. https://doi.org/10.1016/0277-9536(87)90038-4
  9. Chaudhury RR, Rafei UM. Traditional medicine in Asia. Geneva: World Health Organization; 2002.
  10. Ratan ZA, Youn SH, Kwak Y-S, Han C-K, Haidere MF, Kim JK, Min H, Jung Y-J, Hosseinzadeh H, Hyun SH, Cho JY. Adaptogenic effects of Panax ginseng on modulation of immune functions. J. Ginseng Res. 2021;45:32-40. https://doi.org/10.1016/j.jgr.2020.09.004
  11. Nair R, Sellaturay S, Sriprasad S. The history of ginseng in the management of erectile dysfunction in ancient China (3500-2600 BCE). Indian J Urol 2012;28:15-20. https://doi.org/10.4103/0970-1591.94946
  12. Ratan ZA, Haidere MF, Hong YH, Park SH, Lee J-O, Lee J, Cho JY. Pharmacological potential of ginseng and its major component ginsenosides. J. Ginseng Res. 2021;45:199-210. https://doi.org/10.1016/j.jgr.2020.02.004
  13. Adusei-Mensah F, Agjei RO, Awoniyi LO, David LK, Awoniyi FB, Adeyemi OS, Olawuni A, Adegbite A. Prevention and control of acute respiratory viral infections in adult population: a systematic review and meta-analysis on ginseng-based clinical trials. medRxiv 2021. 2021.2007.2023.21260970.
  14. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Ann Rev Pathol 2008;3:499-522. https://doi.org/10.1146/annurev.pathmechdis.3.121806.154316
  15. Park EH, Yum J, Ku KB, Kim HM, Kang YM, Kim JC, Kim JA, Kang YK, Seo SH. Red Ginseng-containing diet helps to protect mice and ferrets from the lethal infection by highly pathogenic H5N1 influenza virus. J. Ginseng Res. 2014;38:40-6. https://doi.org/10.1016/j.jgr.2013.11.012
  16. Quan FS, Compans RW, Cho YK, Kang SM. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Vaccine 2007;25:272-82. https://doi.org/10.1016/j.vaccine.2006.07.041
  17. Cho Y-K, Kim J-E, Woo J-H. Genetic defects in the nef gene are associated with Korean Red Ginseng intake: monitoring of nef sequence polymorphisms over 20 years. J. Ginseng Res. 2017;41:144-50. https://doi.org/10.1016/j.jgr.2016.02.005
  18. Kang LJ, Choi YJ, Lee SG. Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication. Int J Biochem Cell Biol 2013;45:2612-21. https://doi.org/10.1016/j.biocel.2013.08.016
  19. Cho YK, Sung H, Lee HJ, Joo CH, Cho GJ. Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed. Int Immunopharm 2001;1:1295-305. https://doi.org/10.1016/S1567-5769(01)00061-3
  20. Kim BR, Kim JE, Sung H, Cho YK. Long-term follow up of HIV-1-infected Korean haemophiliacs, after infection from a common source of virus. Haemophilia 2015;21:e1-11. https://doi.org/10.1111/hae.12527
  21. Cho Y-K, Kim YK, Lee IC, Choi M, Shin YO. The effect of Korean Red Ginseng (KRG), zidovudine (ZDV), and the combination of KRG and ZDV on HIV-iInfected individuals. J Bacteriol Virol 1996;31:353-60.
  22. Lee MH, Lee BH, Lee S, Choi C. Reduction of hepatitis A virus on FRhK-4 cells treated with Korean red ginseng extract and ginsenosides. J Food Sci 2013;78:M1412-5. https://doi.org/10.1111/1750-3841.12205
  23. Baek SH, Lee JG, Park SY, Bae ON, Kim DH, Park JH. Pectic polysaccharides from Panax ginseng as the antirotavirus principals in ginseng. Biomacromolecules 2010;11:2044-52. https://doi.org/10.1021/bm100397p
  24. Lee JS, Hwang HS, Ko E-J, Lee Y-N, Kwon Y-M, Kim M-C, Kang S-M. Immunomodulatory activity of red ginseng against influenza A virus infection. Nutrients 2014;6:517-29. https://doi.org/10.3390/nu6020517
  25. CHOI K-T. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng CA Meyer. Acta Pharmacol Sin 2008;29:1109-18. https://doi.org/10.1111/j.1745-7254.2008.00869.x
  26. Kitts DD, Hu C. Efficacy and safety of ginseng. Publ Health Nutr 2000;3:473-85. https://doi.org/10.1017/S1368980000000550
  27. Medzhitov R, Janeway CA. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997;91:295-8. https://doi.org/10.1016/S0092-8674(00)80412-2
  28. Hirayama D, Iida T, Nakase H. The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis. Int J Mol Sci 2017;19.
  29. Jang HI, Shin HM. Wild Panax ginseng (Panax ginseng CA Meyer) protects against methotrexateeinduced cell regression by enhancing the immune response in RAW 264.7 macrophages. Am J Chin Med 2010;38:949-60. https://doi.org/10.1142/S0192415X10008378
  30. Youn SH, Lee SM, Han C-K, In G, Park C-K, Hyun SH. Immune activity of polysaccharide fractions isolated from Korean Red Ginseng. Molecules 2020;25:3569. https://doi.org/10.3390/molecules25163569
  31. Shin J-Y, Song J-Y, Yun Y-S, Yang H-O, Rhee D-K, Pyo S. Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunotoxicol Immunpharmacol 2002;24:469-82. https://doi.org/10.1081/IPH-120014730
  32. Mellman I. Dendritic cells: master regulators of the immune response. Canc Immunol Res 2013;1:145-9. https://doi.org/10.1158/2326-6066.CIR-13-0102
  33. Lee YJ, Son YM, Gu MJ, Song KD, Park SM, Song HJ, Kang JS, Woo JS, Jung JH, Yang DC, Han SH, Yun CH. Ginsenoside fractions regulate the action of monocytes and their differentiation into dendritic cells. J. Ginseng Res. 2015;39:29-37. https://doi.org/10.1016/j.jgr.2014.07.003
  34. Kang S, Min H. Ginseng, the 'Immunity Boost': the effects of Panax ginseng on immune system. J. Ginseng Res. 2012;36:354-68. https://doi.org/10.5142/jgr.2012.36.4.354
  35. Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol 2015;16:343-53. https://doi.org/10.1038/ni.3123
  36. Jie YH, Cammisuli S, Baggiolini M. Immunomodulatory effects of Panax ginseng C.A. Meyer in the mouse. Agents Actions 1984;15:386-91. https://doi.org/10.1007/BF01972376
  37. Kenarova B, Neychev H, Hadjiivanova C, Petkov VD. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn J Pharmacol 1990;54:447-54. https://doi.org/10.1254/jjp.54.447
  38. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 1997;35:229-35. https://doi.org/10.1016/S0162-3109(96)00125-7
  39. Heo SB, Lim SW, Jhun JY, Cho ML, Chung BH, Yang CW. Immunological benefits by ginseng through reciprocal regulation of Th17 and Treg cells during cyclosporine-induced immunosuppression. J. Ginseng Res. 2016;40:18-27. https://doi.org/10.1016/j.jgr.2015.04.005
  40. Kim JY, Germolec DR, Luster MI. Panax ginseng as a potential immunomodulator: studies in mice. Immunopharmacol Immunotoxicol 1990;12:257-76. https://doi.org/10.3109/08923979009019672
  41. Rivera E, Ekholm Pettersson F, Inganas M, Paulie S, Gronvik KO. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 2005;23:5411-9. https://doi.org/10.1016/j.vaccine.2005.04.007
  42. Fallah MS, Bayati M, Najafi A, Behmard E, Javad S. Molecular docking investigation of antiviral herbal compounds as potential inhibitors of SARS-CoV-2 spike receptor. Biointerf Res Appl Chem 2021;11:12916-24. https://doi.org/10.33263/BRIAC115.1291612924
  43. Han L-W. Network pharmacologic molecular mechanism of Shenmai Injection in treatment of COVID-19 combined with coronary heart disease. Chin Tradit Herb Drugs 2020:2334-44.
  44. Li X, Lin H, Wang Q, Cui L, Luo H, Luo L. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus pneumonia (COVID-19). Drug Dev Ind Pharm 2020;46:1947-59. https://doi.org/10.1080/03639045.2020.1826510
  45. Wang L-F, Li H-T, Wang Y, Liu X-L, Chen Q-Y, Xu J, Yang M, Zhang X-F, Wang F. Study on mechanism of Shengmai Injection against novel coronavirus pneumonia based on network pharmacology and molecular docking technology. Chin Tradit Herb Drugs 2020:2977-87.
  46. Teitelbaum J, Goudie S. An open-label, pilot trial of HRG80TM red ginseng in chronic fatigue syndrome, fibromyalgia, and post-viral fatigue. Pharmaceuticals 2022;15:43. https://doi.org/10.3390/ph15010043
  47. Khanal P, Chikhale R, Dey YN, Pasha I, Chand S, Gurav N, Ayyanar M, Patil BM, Gurav S. Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19. J Biomol Struct Dyn 2021:1-14.
  48. Han Y, Yang D-U, Huo Y, Pu J, Lee S-J, Yang D-C, Kang SC. In vitro evaluation of anti-lung cancer and anti-COVID-19 effects using fermented black color ginseng extract. Nat Prod Commun 2021;16:1934578X211034387.
  49. Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010;33:492-503. https://doi.org/10.1016/j.immuni.2010.10.002
  50. Chen F, Eckman EA, Eckman CB. Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides. FASEB (Fed Am Soc Exp Biol) J 2006;20:1269-71.
  51. Choi S-H, Jung S-W, Lee B-H, Kim H-J, Hwang S-H, Kim H-K, Nah S-Y. Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions. Front Pharmacol 2015;6.
  52. Leung KW, Wong AS-T. Pharmacology of ginsenosides: a literature review. Chin Med 2010;5:20. https://doi.org/10.1186/1749-8546-5-20
  53. Chapel H, Prevot J, Gaspar HB, Espanol T, Bonilla FA, Solis L, Drabwell J. Primary immune deficiencieseprinciples of care. Front Immunol 2014;5:627. https://doi.org/10.3389/fimmu.2014.00627
  54. Raje N, Dinakar CJI, Clinics A. Overview Immunodef Disorder 2015;35:599-623. https://doi.org/10.1016/j.iac.2015.07.001
  55. Zhou Y, Yang Z, Gao L, Liu W, Liu R, Zhao J, You J. Changes in element accumulation, phenolic metabolism, and antioxidative enzyme activities in the red-skin roots of Panax ginseng. J. Ginseng Res. 2017;41:307-15. https://doi.org/10.1016/j.jgr.2016.06.001
  56. Yun SN, Moon SJ, Ko SK, Im BO, Chung SH. Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Arch Pharm Res (Seoul) 2004;27:790-6. https://doi.org/10.1007/BF02980150
  57. Lee H, Lee S, Jeong D, Kim SJ. Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells. J. Ginseng Res. 2018;42:455-62. https://doi.org/10.1016/j.jgr.2017.05.003
  58. Zhai L, Wang Y, Yu J, Hu S. Enhanced immune responses of chickens to oral vaccination against infectious bursal disease by ginseng stem-leaf saponins. Poultry Sci 2014;93:2473-81. https://doi.org/10.3382/ps.2014-04056
  59. Friedl R, Moeslinger T, Kopp B, Spieckermann PG. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells. Br J Pharmacol 2001;134:1663-70. https://doi.org/10.1038/sj.bjp.0704425
  60. Kim JH, Yi Y-S, Kim M-Y, Cho JY. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J. Ginseng Res. 2017;41:435-43. https://doi.org/10.1016/j.jgr.2016.08.004
  61. JKSS Kim JP, Yoo HY, Yu HJ, Yang HKJ. The effect of ginseng on the nutritional status and the immune functions after curative operations on gastric carcinoma patients. J Korean Surg Soc 1998;54:854.
  62. Lee KG, Son SW. Efficacy of Korean red ginseng in the treatment of atopic dermatitis. J. Ginseng Res. 2011;35:149. https://doi.org/10.5142/jgr.2011.35.2.149
  63. Yun TK, Choi SY, Yun HY. Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng? J Kor Med Sci 2001;16:S19. https://doi.org/10.3346/jkms.2001.16.s.s19
  64. Liang Z, Zhu H, Wang X, Jing B, Li Z, Xia X, Sun H, Yang Y, Zhang W, Shi L, Zeng H, Sun B. Adjuvants for coronavirus vaccines. Front Immunol 2020;11:589833. https://doi.org/10.3389/fimmu.2020.589833